Header Logo

Connection

GREGORY GLADISH to Paclitaxel

Back to Details
This is a "connection" page, showing publications GREGORY GLADISH has written about Paclitaxel.
GREGORY GLADISH
Connection Strength
0.013
Paclitaxel
  1. Phase 1b study of motesanib, an oral angiogenesis inhibitor, in combination with carboplatin/paclitaxel and/or panitumumab for the treatment of advanced non-small cell lung cancer. Clin Cancer Res. 2010 Jan 01; 16(1):279-90.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.